ContributorsPublishersAdvertisers

The Evolving Role of Prognostic Markers for CLL in the Era of Novel Agents

onclive.com
 2021-12-03

Deborah M. Stephens, DO, discusses her approach to treating a patients with chronic lymphocytic leukemia, how CAR T-cell therapy may fit into the treatment paradigm, and the numerous trials that have shown promise in this space. Although the treatment armamentarium has expanded significantly for the treatment of patients with...

www.onclive.com

Comments / 0

Comments / 0